Please turn JavaScript on
READ
PUBLISH
My newsFind FeedsDelivery settingsPlansMy earnings
HelpBlog
Login
Find more feeds
header-image

BIOTECanada

Subscribe to BIOTECanada’s news feed.

Click on “Follow” and decide if you want to get news from BIOTECanada via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to BIOTECanada comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from BIOTECanada which you are really interested in. Click on the blue “Filter” button below to get started.

Website title: Home - BIOTECanada

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  2.48 / week

Message History

Morphocell Technologies Inc – Completes US$50 Million Series A Financing

LAVAL, QC, Dec. 1, 2025 /PRNewswire/ – Morphocell Technologies Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement, today announced the completion of its US$50 million Series A financing following a US$10 million add-on led by Investissement Québec, the province’s leading economic development corporation, and CDP Venture Capital,...

Read full story
AbbVie and adMare BioInnovations – Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators ...

  • National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie’s commitment to a thriving biotech ecosystem in Quebec 
  • One biotech will receive a year of laboratory and office space including access to shared equipment and services at no cost at the adMare Innovation Centre in Montreal, as well as access to AbbVie’s scie...

    • Read full story
    CSL Seqirus – Enhanced Influenza Vaccines Provide Essential Protection for Older Adults: CSL Seqirus Presents New Ev...

    CSL Seqirus, a global leader in seasonal influenza prevention (ASX: CSL), has shared new actionable real-world evidence (RWE) reinforcing the critical role of enhanced influenza vaccines in preventing influenza and reducing the risks of severe disease at the 10th European Scientific Working group on Influenza (ESWI) conference in Valencia.

    Montreal, Quebec 24 Nov 20...

    Read full story
    NervGen Pharma – Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Functi...

  • Week 16 follow-up data, coupled with blinded exit interviews conducted up to 364 days after the study period, confirm durable
    and wide-ranging upper and lower-body improvements compared to placebo
  • Participant-reported outcomes highlight substantial improvements in bladder control and muscle spasticity compared to placebo
  • Stat...

    • Read full story
    Kapoose Creek Bio – Recent awards power two new studies into drug discovery and development

    In two new research collaborations between McMaster University and biotechnology firm Kapoose Creek Bio (KC Bio), academic and industry scientists are working together to discover and develop novel medicines.

    Backed by two of Canada’s premier research funding programs — href="htt...

    Read full story